English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 153 | Tables: 141 | Medical Care
The global Preclinical DMPK Studies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is used to assess the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate. This information is essential for understanding how a drug will behave in the body and for designing safe and effective clinical trials.
DMPK studies can be performed in vitro or in vivo. In vitro DMPK studies are typically used to screen a large number of compounds for their ADME properties and to identify promising candidates for further development. In vivo DMPK studies are typically performed later in drug development, after a compound has been shown to have promising ADME properties in vitro.
The North American market for Preclinical DMPK Studies is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Preclinical DMPK Studies is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Preclinical DMPK Studies in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Preclinical DMPK Studies include Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Preclinical DMPK Studies market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Preclinical DMPK Studies. The Preclinical DMPK Studies market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Preclinical DMPK Studies market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Preclinical DMPK Studies manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Charles River
Labcorp
Eurofins Scientific
PPD
Inotiv
ChemPartner
Evotec
Medicilon
Crown Bioscience
Jubilant Biosys
Creative Biolabs
Allucent
Sai Life Sciences
Sygnature Discovery
Q2 Solutions
Invitrocue
Frontage
BioDuro-Sundia
Wuxi AppTec
Pharmaron
JOINN Laboratories
Tigermed
Segment by Type
In Vitro
In Vivo
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Preclinical DMPK Studies companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical DMPK Studies Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vitro
1.2.3 In Vivo
1.3 Market by Application
1.3.1 Global Preclinical DMPK Studies Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical DMPK Studies Market Perspective (2021–2032)
2.2 Global Preclinical DMPK Studies Growth Trends by Region
2.2.1 Global Preclinical DMPK Studies Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Preclinical DMPK Studies Historic Market Size by Region (2021–2026)
2.2.3 Preclinical DMPK Studies Forecasted Market Size by Region (2027–2032)
2.3 Preclinical DMPK Studies Market Dynamics
2.3.1 Preclinical DMPK Studies Industry Trends
2.3.2 Preclinical DMPK Studies Market Drivers
2.3.3 Preclinical DMPK Studies Market Challenges
2.3.4 Preclinical DMPK Studies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical DMPK Studies Players by Revenue
3.1.1 Global Top Preclinical DMPK Studies Players by Revenue (2021–2026)
3.1.2 Global Preclinical DMPK Studies Revenue Market Share by Players (2021–2026)
3.2 Global Top Preclinical DMPK Studies Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Preclinical DMPK Studies Revenue
3.4 Global Preclinical DMPK Studies Market Concentration Ratio
3.4.1 Global Preclinical DMPK Studies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical DMPK Studies Revenue in 2025
3.5 Global Key Players of Preclinical DMPK Studies Head Offices and Areas Served
3.6 Global Key Players of Preclinical DMPK Studies, Products and Applications
3.7 Global Key Players of Preclinical DMPK Studies, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Preclinical DMPK Studies Breakdown Data by Type
4.1 Global Preclinical DMPK Studies Historic Market Size by Type (2021–2026)
4.2 Global Preclinical DMPK Studies Forecasted Market Size by Type (2027–2032)
5 Preclinical DMPK Studies Breakdown Data by Application
5.1 Global Preclinical DMPK Studies Historic Market Size by Application (2021–2026)
5.2 Global Preclinical DMPK Studies Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Preclinical DMPK Studies Market Size (2021–2032)
6.2 North America Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Preclinical DMPK Studies Market Size by Country (2021–2026)
6.4 North America Preclinical DMPK Studies Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical DMPK Studies Market Size (2021–2032)
7.2 Europe Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Preclinical DMPK Studies Market Size by Country (2021–2026)
7.4 Europe Preclinical DMPK Studies Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Preclinical DMPK Studies Market Size (2021–2032)
8.2 Asia-Pacific Preclinical DMPK Studies Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Preclinical DMPK Studies Market Size by Region (2021–2026)
8.4 Asia-Pacific Preclinical DMPK Studies Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Preclinical DMPK Studies Market Size (2021–2032)
9.2 Latin America Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Preclinical DMPK Studies Market Size by Country (2021–2026)
9.4 Latin America Preclinical DMPK Studies Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical DMPK Studies Market Size (2021–2032)
10.2 Middle East & Africa Preclinical DMPK Studies Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Preclinical DMPK Studies Market Size by Country (2021–2026)
10.4 Middle East & Africa Preclinical DMPK Studies Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Preclinical DMPK Studies Introduction
11.1.4 Charles River Revenue in Preclinical DMPK Studies Business (2021–2026)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Preclinical DMPK Studies Introduction
11.2.4 Labcorp Revenue in Preclinical DMPK Studies Business (2021–2026)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Preclinical DMPK Studies Introduction
11.3.4 Eurofins Scientific Revenue in Preclinical DMPK Studies Business (2021–2026)
11.3.5 Eurofins Scientific Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Preclinical DMPK Studies Introduction
11.4.4 PPD Revenue in Preclinical DMPK Studies Business (2021–2026)
11.4.5 PPD Recent Development
11.5 Inotiv
11.5.1 Inotiv Company Details
11.5.2 Inotiv Business Overview
11.5.3 Inotiv Preclinical DMPK Studies Introduction
11.5.4 Inotiv Revenue in Preclinical DMPK Studies Business (2021–2026)
11.5.5 Inotiv Recent Development
11.6 ChemPartner
11.6.1 ChemPartner Company Details
11.6.2 ChemPartner Business Overview
11.6.3 ChemPartner Preclinical DMPK Studies Introduction
11.6.4 ChemPartner Revenue in Preclinical DMPK Studies Business (2021–2026)
11.6.5 ChemPartner Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Preclinical DMPK Studies Introduction
11.7.4 Evotec Revenue in Preclinical DMPK Studies Business (2021–2026)
11.7.5 Evotec Recent Development
11.8 Medicilon
11.8.1 Medicilon Company Details
11.8.2 Medicilon Business Overview
11.8.3 Medicilon Preclinical DMPK Studies Introduction
11.8.4 Medicilon Revenue in Preclinical DMPK Studies Business (2021–2026)
11.8.5 Medicilon Recent Development
11.9 Crown Bioscience
11.9.1 Crown Bioscience Company Details
11.9.2 Crown Bioscience Business Overview
11.9.3 Crown Bioscience Preclinical DMPK Studies Introduction
11.9.4 Crown Bioscience Revenue in Preclinical DMPK Studies Business (2021–2026)
11.9.5 Crown Bioscience Recent Development
11.10 Jubilant Biosys
11.10.1 Jubilant Biosys Company Details
11.10.2 Jubilant Biosys Business Overview
11.10.3 Jubilant Biosys Preclinical DMPK Studies Introduction
11.10.4 Jubilant Biosys Revenue in Preclinical DMPK Studies Business (2021–2026)
11.10.5 Jubilant Biosys Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Preclinical DMPK Studies Introduction
11.11.4 Creative Biolabs Revenue in Preclinical DMPK Studies Business (2021–2026)
11.11.5 Creative Biolabs Recent Development
11.12 Allucent
11.12.1 Allucent Company Details
11.12.2 Allucent Business Overview
11.12.3 Allucent Preclinical DMPK Studies Introduction
11.12.4 Allucent Revenue in Preclinical DMPK Studies Business (2021–2026)
11.12.5 Allucent Recent Development
11.13 Sai Life Sciences
11.13.1 Sai Life Sciences Company Details
11.13.2 Sai Life Sciences Business Overview
11.13.3 Sai Life Sciences Preclinical DMPK Studies Introduction
11.13.4 Sai Life Sciences Revenue in Preclinical DMPK Studies Business (2021–2026)
11.13.5 Sai Life Sciences Recent Development
11.14 Sygnature Discovery
11.14.1 Sygnature Discovery Company Details
11.14.2 Sygnature Discovery Business Overview
11.14.3 Sygnature Discovery Preclinical DMPK Studies Introduction
11.14.4 Sygnature Discovery Revenue in Preclinical DMPK Studies Business (2021–2026)
11.14.5 Sygnature Discovery Recent Development
11.15 Q2 Solutions
11.15.1 Q2 Solutions Company Details
11.15.2 Q2 Solutions Business Overview
11.15.3 Q2 Solutions Preclinical DMPK Studies Introduction
11.15.4 Q2 Solutions Revenue in Preclinical DMPK Studies Business (2021–2026)
11.15.5 Q2 Solutions Recent Development
11.16 Invitrocue
11.16.1 Invitrocue Company Details
11.16.2 Invitrocue Business Overview
11.16.3 Invitrocue Preclinical DMPK Studies Introduction
11.16.4 Invitrocue Revenue in Preclinical DMPK Studies Business (2021–2026)
11.16.5 Invitrocue Recent Development
11.17 Frontage
11.17.1 Frontage Company Details
11.17.2 Frontage Business Overview
11.17.3 Frontage Preclinical DMPK Studies Introduction
11.17.4 Frontage Revenue in Preclinical DMPK Studies Business (2021–2026)
11.17.5 Frontage Recent Development
11.18 BioDuro-Sundia
11.18.1 BioDuro-Sundia Company Details
11.18.2 BioDuro-Sundia Business Overview
11.18.3 BioDuro-Sundia Preclinical DMPK Studies Introduction
11.18.4 BioDuro-Sundia Revenue in Preclinical DMPK Studies Business (2021–2026)
11.18.5 BioDuro-Sundia Recent Development
11.19 Wuxi AppTec
11.19.1 Wuxi AppTec Company Details
11.19.2 Wuxi AppTec Business Overview
11.19.3 Wuxi AppTec Preclinical DMPK Studies Introduction
11.19.4 Wuxi AppTec Revenue in Preclinical DMPK Studies Business (2021–2026)
11.19.5 Wuxi AppTec Recent Development
11.20 Pharmaron
11.20.1 Pharmaron Company Details
11.20.2 Pharmaron Business Overview
11.20.3 Pharmaron Preclinical DMPK Studies Introduction
11.20.4 Pharmaron Revenue in Preclinical DMPK Studies Business (2021–2026)
11.20.5 Pharmaron Recent Development
11.21 JOINN Laboratories
11.21.1 JOINN Laboratories Company Details
11.21.2 JOINN Laboratories Business Overview
11.21.3 JOINN Laboratories Preclinical DMPK Studies Introduction
11.21.4 JOINN Laboratories Revenue in Preclinical DMPK Studies Business (2021–2026)
11.21.5 JOINN Laboratories Recent Development
11.22 Tigermed
11.22.1 Tigermed Company Details
11.22.2 Tigermed Business Overview
11.22.3 Tigermed Preclinical DMPK Studies Introduction
11.22.4 Tigermed Revenue in Preclinical DMPK Studies Business (2021–2026)
11.22.5 Tigermed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Preclinical DMPK Studies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of In Vitro
Table 3. Key Players of In Vivo
Table 4. Global Preclinical DMPK Studies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Preclinical DMPK Studies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Preclinical DMPK Studies Market Size by Region (US$ Million), 2021–2026
Table 7. Global Preclinical DMPK Studies Market Share by Region (2021–2026)
Table 8. Global Preclinical DMPK Studies Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Preclinical DMPK Studies Market Share by Region (2027–2032)
Table 10. Preclinical DMPK Studies Market Trends
Table 11. Preclinical DMPK Studies Market Drivers
Table 12. Preclinical DMPK Studies Market Challenges
Table 13. Preclinical DMPK Studies Market Restraints
Table 14. Global Preclinical DMPK Studies Revenue by Players (US$ Million), 2021–2026
Table 15. Global Preclinical DMPK Studies Market Share by Players (2021–2026)
Table 16. Global Top Preclinical DMPK Studies Players by Tier (Tier 1, Tier 2, and Tier 3), based on Preclinical DMPK Studies Revenue, 2025
Table 17. Ranking of Global Top Preclinical DMPK Studies Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Preclinical DMPK Studies Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Preclinical DMPK Studies, Headquarters and Area Served
Table 20. Global Key Players of Preclinical DMPK Studies, Products and Applications
Table 21. Global Key Players of Preclinical DMPK Studies, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Preclinical DMPK Studies Market Size by Type (US$ Million), 2021–2026
Table 24. Global Preclinical DMPK Studies Revenue Market Share by Type (2021–2026)
Table 25. Global Preclinical DMPK Studies Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Preclinical DMPK Studies Revenue Market Share by Type (2027–2032)
Table 27. Global Preclinical DMPK Studies Market Size by Application (US$ Million), 2021–2026
Table 28. Global Preclinical DMPK Studies Revenue Market Share by Application (2021–2026)
Table 29. Global Preclinical DMPK Studies Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Preclinical DMPK Studies Revenue Market Share by Application (2027–2032)
Table 31. North America Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
Table 33. North America Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Preclinical DMPK Studies Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Preclinical DMPK Studies Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Preclinical DMPK Studies Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Preclinical DMPK Studies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Preclinical DMPK Studies Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Preclinical DMPK Studies Market Size by Country (US$ Million), 2027–2032
Table 46. Charles River Company Details
Table 47. Charles River Business Overview
Table 48. Charles River Preclinical DMPK Studies Product
Table 49. Charles River Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 50. Charles River Recent Development
Table 51. Labcorp Company Details
Table 52. Labcorp Business Overview
Table 53. Labcorp Preclinical DMPK Studies Product
Table 54. Labcorp Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 55. Labcorp Recent Development
Table 56. Eurofins Scientific Company Details
Table 57. Eurofins Scientific Business Overview
Table 58. Eurofins Scientific Preclinical DMPK Studies Product
Table 59. Eurofins Scientific Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 60. Eurofins Scientific Recent Development
Table 61. PPD Company Details
Table 62. PPD Business Overview
Table 63. PPD Preclinical DMPK Studies Product
Table 64. PPD Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 65. PPD Recent Development
Table 66. Inotiv Company Details
Table 67. Inotiv Business Overview
Table 68. Inotiv Preclinical DMPK Studies Product
Table 69. Inotiv Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 70. Inotiv Recent Development
Table 71. ChemPartner Company Details
Table 72. ChemPartner Business Overview
Table 73. ChemPartner Preclinical DMPK Studies Product
Table 74. ChemPartner Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 75. ChemPartner Recent Development
Table 76. Evotec Company Details
Table 77. Evotec Business Overview
Table 78. Evotec Preclinical DMPK Studies Product
Table 79. Evotec Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 80. Evotec Recent Development
Table 81. Medicilon Company Details
Table 82. Medicilon Business Overview
Table 83. Medicilon Preclinical DMPK Studies Product
Table 84. Medicilon Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 85. Medicilon Recent Development
Table 86. Crown Bioscience Company Details
Table 87. Crown Bioscience Business Overview
Table 88. Crown Bioscience Preclinical DMPK Studies Product
Table 89. Crown Bioscience Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 90. Crown Bioscience Recent Development
Table 91. Jubilant Biosys Company Details
Table 92. Jubilant Biosys Business Overview
Table 93. Jubilant Biosys Preclinical DMPK Studies Product
Table 94. Jubilant Biosys Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 95. Jubilant Biosys Recent Development
Table 96. Creative Biolabs Company Details
Table 97. Creative Biolabs Business Overview
Table 98. Creative Biolabs Preclinical DMPK Studies Product
Table 99. Creative Biolabs Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 100. Creative Biolabs Recent Development
Table 101. Allucent Company Details
Table 102. Allucent Business Overview
Table 103. Allucent Preclinical DMPK Studies Product
Table 104. Allucent Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 105. Allucent Recent Development
Table 106. Sai Life Sciences Company Details
Table 107. Sai Life Sciences Business Overview
Table 108. Sai Life Sciences Preclinical DMPK Studies Product
Table 109. Sai Life Sciences Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 110. Sai Life Sciences Recent Development
Table 111. Sygnature Discovery Company Details
Table 112. Sygnature Discovery Business Overview
Table 113. Sygnature Discovery Preclinical DMPK Studies Product
Table 114. Sygnature Discovery Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 115. Sygnature Discovery Recent Development
Table 116. Q2 Solutions Company Details
Table 117. Q2 Solutions Business Overview
Table 118. Q2 Solutions Preclinical DMPK Studies Product
Table 119. Q2 Solutions Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 120. Q2 Solutions Recent Development
Table 121. Invitrocue Company Details
Table 122. Invitrocue Business Overview
Table 123. Invitrocue Preclinical DMPK Studies Product
Table 124. Invitrocue Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 125. Invitrocue Recent Development
Table 126. Frontage Company Details
Table 127. Frontage Business Overview
Table 128. Frontage Preclinical DMPK Studies Product
Table 129. Frontage Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 130. Frontage Recent Development
Table 131. BioDuro-Sundia Company Details
Table 132. BioDuro-Sundia Business Overview
Table 133. BioDuro-Sundia Preclinical DMPK Studies Product
Table 134. BioDuro-Sundia Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 135. BioDuro-Sundia Recent Development
Table 136. Wuxi AppTec Company Details
Table 137. Wuxi AppTec Business Overview
Table 138. Wuxi AppTec Preclinical DMPK Studies Product
Table 139. Wuxi AppTec Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 140. Wuxi AppTec Recent Development
Table 141. Pharmaron Company Details
Table 142. Pharmaron Business Overview
Table 143. Pharmaron Preclinical DMPK Studies Product
Table 144. Pharmaron Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 145. Pharmaron Recent Development
Table 146. JOINN Laboratories Company Details
Table 147. JOINN Laboratories Business Overview
Table 148. JOINN Laboratories Preclinical DMPK Studies Product
Table 149. JOINN Laboratories Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 150. JOINN Laboratories Recent Development
Table 151. Tigermed Company Details
Table 152. Tigermed Business Overview
Table 153. Tigermed Preclinical DMPK Studies Product
Table 154. Tigermed Revenue in Preclinical DMPK Studies Business (US$ Million), 2021–2026
Table 155. Tigermed Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. Preclinical DMPK Studies Picture
Figure 2. Global Preclinical DMPK Studies Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Preclinical DMPK Studies Market Share by Type: 2025 vs 2032
Figure 4. In Vitro Features
Figure 5. In Vivo Features
Figure 6. Global Preclinical DMPK Studies Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Preclinical DMPK Studies Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Preclinical DMPK Studies Report Years Considered
Figure 12. Global Preclinical DMPK Studies Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Preclinical DMPK Studies Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Preclinical DMPK Studies Market Share by Region: 2025 vs 2032
Figure 15. Global Preclinical DMPK Studies Market Share by Players in 2025
Figure 16. Global Preclinical DMPK Studies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Preclinical DMPK Studies Revenue in 2025
Figure 18. North America Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Preclinical DMPK Studies Market Share by Country (2021–2032)
Figure 20. United States Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Preclinical DMPK Studies Market Share by Country (2021–2032)
Figure 24. Germany Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Preclinical DMPK Studies Market Share by Region (2021–2032)
Figure 32. China Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Preclinical DMPK Studies Market Share by Country (2021–2032)
Figure 40. Mexico Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Preclinical DMPK Studies Market Share by Country (2021–2032)
Figure 44. Israel Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Preclinical DMPK Studies Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Charles River Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 48. Labcorp Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 49. Eurofins Scientific Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 50. PPD Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 51. Inotiv Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 52. ChemPartner Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 53. Evotec Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 54. Medicilon Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 55. Crown Bioscience Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 56. Jubilant Biosys Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 57. Creative Biolabs Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 58. Allucent Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 59. Sai Life Sciences Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 60. Sygnature Discovery Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 61. Q2 Solutions Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 62. Invitrocue Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 63. Frontage Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 64. BioDuro-Sundia Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 65. Wuxi AppTec Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 66. Pharmaron Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 67. JOINN Laboratories Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 68. Tigermed Revenue Growth Rate in Preclinical DMPK Studies Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
